Chuang Yi Biotech co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was TWD 78.299 million compared to TWD 48.042 million a year ago. Operating loss was TWD 11.344 million compared to TWD 5.786 million a year ago. Net loss was TWD 16.532 million compared to TWD 7.611 million a year ago. Basic loss per share was TWD 0.49 compared to TWD 0.28 a year ago.